Otusophta Oy
3462968-3ActiveFinnish biotech startup revolutionizing dry eye disease treatment technology.
Biotechnology Startupotusophta.com
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2024
- Grunnlagt
Nøkkelbeslutningstakere
Roland Mirow
Chief commercialization officer
Filip Ekholm
Chief Scientific Officer
Kari Lehmussaari
Chief Executive Officer
Janika Olenius
Product Development Manager
+1 flere kontakter i Funnelfeedr
Beskrivelse
OtusOphta Ltd. is a Finnish biotechnology startup established in August 2024. Their core mission is to challenge current treatments for dry eye disease (DED) by developing innovative solutions. The company focuses on enhancing the tear film lipid layer (TFLL) function using improved human tear film...